Skip to main content

Global Medical Devices Market Size worth USD 657.98 Billion by 2028, Exhibiting a CAGR of 5.4%

Written by Customer Service on . Posted in Mergers And Acquisitions.

Key Players Covered in the Medical Devices Market Research Report Are Medtronic PLC, Abbott, Siemens Healthineers, Koninklijke Philips N.V., Stryker Corporation, F. Hoffman-La Roche, Becton Dickinson, GE, Healthcare, Boston Scientific Corporation and other key market players.

Pune, India, Jan. 24, 2022 (GLOBE NEWSWIRE) — The global medical devices market size is expected to reach USD 657.98 billion by 2028, exhibiting a CAGR of 5.4% during the forecast period. The rising geriatric population will boost the growth of the market. Fortune Business Insights, in a new study, titled “Medical Devices Market Size, 2021-2028.” states that in-vitro diagnostics is expected to lead the market. According to the study, the US IVD segment covered 15.5% of the global medical devices market share in 2020.

Key Development:

January 2021: Stryker announced that it had acquired OrthoSensor Inc., a leader in the digital evolution of musculoskeletal care and sensor technology for total joint replacement, in order to include its Verasense intraoperative sensor technology in its portfolio of Mako robots.


Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/medical-devices-market-100085


Driving Factor:

Rising Prevalence of Chronic Disorders and Demand for Preventive Healthcare to Spur Growth

The rising incidence of chronic diseases such as diabetes, cancer, heart diseases is fueling the demand for various medical devices in North America. According to the National Center for Chronic Disease Prevention and Health Promotion (CDC), around six in every ten people in the U.S live with one of the above-mentioned chronic diseases.

This further increases demand for medical devices and encourages several companies to introduce innovative technologies in the field. With the rising prevalence of chronic diseases, the need for preventive healthcare will increase exponentially. This is another factor driving the market. Medical device manufacturers around the world are likely to invest in the development of new medical devices and update the existing ones. All the above factors are anticipated to create a growth engine for the market during the forecast period.


COVID-19 Impact:

Postponement of Non Compulsory Procedures to Inhibit Market amid Coronavirus

The outbreak had a minimal impact on the medical device industry due to the demand for medical and hospital supplies to manage patients positively with COVID-19. However, the reduced need for orthopedic devices, dental devices, and cardiovascular devices has negatively affected the medical devices market growth. Moreover, the postponement of elective surgeries, minimally invasive surgery, ophthalmology, wound management have further impacted the market amid the coronavirus pandemic.


Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/medical-devices-market-100085


Regional Insights:

Heavy R&D Investments to Aid Development in North America

North America is expected to emerge dominant over the forecast tenure. The presence of many companies, coupled with substantial R&D investments, is boosting the market in North America. Other regions such as Asia Pacific are expected to show considerable growth opportunities in the market during the forecast period.

Competitive Landscape:

Key Players are Adopting Innovative Strategies to Remain at the Forefront

In December 2020, Koninklijke Philips N.V. announced the acquisition of the U.S.-based cardiac diagnostics and monitoring company BioTelemetry to expand its remote care product offerings. Such growth strategies adopted by leading companies will enable growth in the market. Some of the other players present in the global market include GE Healthcare, DePuy Synthes, Ethicon LLC., Baxter International Inc., Medtronic, and Philips Healthcare. Companies are adopting strategies to improve their revenue shares market.


Quick Buy –  Medical Devices Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100085


The Report Lists the Companies in the Global Market:

  • Medtronic (Dublin, Ireland)
  • Stryker (Kalamazoo, United States)
  • Fresenius SE & Co. KGaA (Bad Homburg, Germany)
  • Koninklijke Philips N.V. (Amsterdam, Netherlands)
  • F. Hoffmann-La Roche Ltd (Basel, Switzerland)
  • General Electric Company (Chicago, United States)
  • Siemens Healthineers AG (Munich, Germany)
  • BD (Franklin Lakes, United States)
  • Boston Scientific Corporation (Marlborough, United States)
  • Johnson & Johnson Services, Inc. (New Brunswick, United States)
  • Other Players


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/medical-devices-market-100085


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Contact Us:

US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs


Press Release: https://www.fortunebusinessinsights.com/press-release/medical-devices-market-9074

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.